# L_2008257EN.01002101.xml

| 25.9.2008 | EN | Official Journal of the European Union | L 257/21 |
| --- | --- | --- | --- |

25.9.2008

EN

Official Journal of the European Union

L 257/21

---

DECISION OF THE EEA JOINT COMMITTEE

No 61/2008

of 6 June 2008

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area, as amended by the Protocol adjusting the Agreement on the European Economic Area, hereinafter referred to as ‘the Agreement’, and in particular Article 98 thereof,

Whereas:

| (1) | Annex II to the Agreement was amended by Decision of the EEA Joint Committee No 46/2008 of 25 April 2008 (1). |
| --- | --- |

(1)

Annex II to the Agreement was amended by Decision of the EEA Joint Committee No 46/2008 of 25 April 2008 (1).

| (2) | Commission Directive 2007/62/EC of 4 October 2007 amending certain Annexes to Council Directives 86/362/EEC and 90/642/EEC as regards maximum residue levels for bifenazate, pethoxamid, pyrimethanil and rimsulfuron (2) is to be incorporated into the Agreement. |
| --- | --- |

(2)

Commission Directive 2007/62/EC of 4 October 2007 amending certain Annexes to Council Directives 86/362/EEC and 90/642/EEC as regards maximum residue levels for bifenazate, pethoxamid, pyrimethanil and rimsulfuron (2) is to be incorporated into the Agreement.

| (3) | Commission Directive 2007/73/EC of 13 December 2007 amending certain Annexes to Council Directives 86/362/EEC and 90/642/EEC as regards maximum residue levels for acetamiprid, atrazine, deltamethrin, imazalil, indoxacarb, pendimethalin, pymetrozine, pyraclostrobin, thiacloprid and trifloxystrobin (3) is to be incorporated into the Agreement. |
| --- | --- |

(3)

Commission Directive 2007/73/EC of 13 December 2007 amending certain Annexes to Council Directives 86/362/EEC and 90/642/EEC as regards maximum residue levels for acetamiprid, atrazine, deltamethrin, imazalil, indoxacarb, pendimethalin, pymetrozine, pyraclostrobin, thiacloprid and trifloxystrobin (3) is to be incorporated into the Agreement.

| (4) | This Decision is not to apply to Liechtenstein, |
| --- | --- |

(4)

This Decision is not to apply to Liechtenstein,

HAS DECIDED AS FOLLOWS:

Article 1

The following indents shall be added in points 38 (Council Directive 86/362/EEC) and 54 (Council Directive 90/642/EEC) of Chapter XII of Annex II to the Agreement:

| ‘— | 32007 L 0062: Commission Directive 2007/62/EC of 4 October 2007 (OJ L 260, 5.10.2007, p. 4), |
| --- | --- |

‘—

32007 L 0062: Commission Directive 2007/62/EC of 4 October 2007 (OJ L 260, 5.10.2007, p. 4),

| — | 32007 L 0073: Commission Directive 2007/73/EC of 13 December 2007 (OJ L 329, 14.12.2007, p. 40).’ |
| --- | --- |

—

32007 L 0073: Commission Directive 2007/73/EC of 13 December 2007 (OJ L 329, 14.12.2007, p. 40).’

Article 2

The texts of Directives 2007/62/EC and 2007/73/EC in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.

Article 3

This Decision shall enter into force on 7 June 2008, provided that all the notifications under Article 103(1) of the Agreement have been made to the EEA Joint Committee (*1).

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

Done at Brussels, 6 June 2008.

For the EEA Joint Committee

The President

Alan SEATTER

---

(1)  
  OJ L 223, 21.8.2008, p. 40.

1

(2)  
  OJ L 260, 5.10.2007, p. 4.

2

(3)  
  OJ L 329, 14.12.2007, p. 40.

3

(*1)  No constitutional requirements indicated.

*1

---